IIR & IBC Finance is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
JMCR manages the Viva Ventures Biotech Fund which invests in early-stage, first-in-class, drug discovery startups. Our advantages include our location and client base which gives us access to the United States and the emerging biotech industry in China, a $20 trillion market.
We are able to source and invest in innovative best biotech startups. These startups are de-risked through our partnership with well-trained technicians and an integrated team of leaders from all scientific disciplines in Viva Biotech Drug Discovery Accelerators. There are 24 experienced partners who are all scientists and entrepreneurs and have collectively contributed 5 approved and 50 clinical-stage drugs. They are based in both Asia and the US. We can achieve high returns with an annual ROI of 300%, by investing at the earliest stages when there is a lack of peer competition. Our model uses 5x greater capital efficiency to achieve the same milestones compared to industry averages.